![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: CSK |
Gene summary for CSK |
![]() |
Gene information | Species | Human | Gene symbol | CSK | Gene ID | 1445 |
Gene name | C-terminal Src kinase | |
Gene Alias | CSK | |
Cytomap | 15q24.1 | |
Gene Type | protein-coding | GO ID | GO:0000165 | UniProtAcc | A8K3B6 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
1445 | CSK | LZE4T | Human | Esophagus | ESCC | 1.54e-06 | 1.70e-01 | 0.0811 |
1445 | CSK | LZE7T | Human | Esophagus | ESCC | 2.59e-21 | 5.44e-01 | 0.0667 |
1445 | CSK | LZE22D1 | Human | Esophagus | HGIN | 2.86e-02 | 8.16e-02 | 0.0595 |
1445 | CSK | LZE22T | Human | Esophagus | ESCC | 1.32e-02 | 2.18e-01 | 0.068 |
1445 | CSK | LZE24T | Human | Esophagus | ESCC | 3.22e-08 | 1.71e-01 | 0.0596 |
1445 | CSK | LZE6T | Human | Esophagus | ESCC | 1.91e-05 | 2.49e-01 | 0.0845 |
1445 | CSK | P1T-E | Human | Esophagus | ESCC | 2.84e-15 | 3.53e-01 | 0.0875 |
1445 | CSK | P2T-E | Human | Esophagus | ESCC | 2.34e-18 | 2.72e-01 | 0.1177 |
1445 | CSK | P4T-E | Human | Esophagus | ESCC | 3.74e-26 | 4.67e-01 | 0.1323 |
1445 | CSK | P5T-E | Human | Esophagus | ESCC | 1.32e-05 | 1.04e-01 | 0.1327 |
1445 | CSK | P8T-E | Human | Esophagus | ESCC | 3.59e-17 | 3.19e-01 | 0.0889 |
1445 | CSK | P9T-E | Human | Esophagus | ESCC | 3.74e-13 | 2.16e-01 | 0.1131 |
1445 | CSK | P10T-E | Human | Esophagus | ESCC | 3.11e-13 | 2.18e-01 | 0.116 |
1445 | CSK | P11T-E | Human | Esophagus | ESCC | 2.51e-07 | 2.32e-01 | 0.1426 |
1445 | CSK | P12T-E | Human | Esophagus | ESCC | 5.92e-10 | 1.84e-01 | 0.1122 |
1445 | CSK | P15T-E | Human | Esophagus | ESCC | 3.84e-20 | 2.94e-01 | 0.1149 |
1445 | CSK | P16T-E | Human | Esophagus | ESCC | 2.55e-13 | 2.19e-01 | 0.1153 |
1445 | CSK | P19T-E | Human | Esophagus | ESCC | 8.42e-11 | 4.29e-01 | 0.1662 |
1445 | CSK | P20T-E | Human | Esophagus | ESCC | 2.80e-12 | 1.77e-01 | 0.1124 |
1445 | CSK | P21T-E | Human | Esophagus | ESCC | 1.17e-16 | 1.26e-01 | 0.1617 |
Page: 1 2 3 4 5 6 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003367411 | Liver | HCC | positive regulation of kinase activity | 230/7958 | 467/18723 | 1.72e-03 | 8.95e-03 | 230 |
GO:0009100 | Liver | HCC | glycoprotein metabolic process | 193/7958 | 387/18723 | 1.89e-03 | 9.62e-03 | 193 |
GO:000686921 | Liver | HCC | lipid transport | 198/7958 | 398/18723 | 1.92e-03 | 9.78e-03 | 198 |
GO:00016553 | Liver | HCC | urogenital system development | 170/7958 | 338/18723 | 2.15e-03 | 1.08e-02 | 170 |
GO:004578512 | Liver | HCC | positive regulation of cell adhesion | 215/7958 | 437/18723 | 2.53e-03 | 1.22e-02 | 215 |
GO:19049501 | Liver | HCC | negative regulation of establishment of protein localization | 72/7958 | 131/18723 | 2.65e-03 | 1.27e-02 | 72 |
GO:00429961 | Liver | HCC | regulation of Golgi to plasma membrane protein transport | 9/7958 | 10/18723 | 2.79e-03 | 1.31e-02 | 9 |
GO:00303012 | Liver | HCC | cholesterol transport | 65/7958 | 117/18723 | 2.95e-03 | 1.38e-02 | 65 |
GO:001095121 | Liver | HCC | negative regulation of endopeptidase activity | 129/7958 | 252/18723 | 3.17e-03 | 1.47e-02 | 129 |
GO:00018222 | Liver | HCC | kidney development | 148/7958 | 293/18723 | 3.25e-03 | 1.49e-02 | 148 |
GO:00720012 | Liver | HCC | renal system development | 152/7958 | 302/18723 | 3.45e-03 | 1.56e-02 | 152 |
GO:00159182 | Liver | HCC | sterol transport | 71/7958 | 130/18723 | 3.49e-03 | 1.58e-02 | 71 |
GO:003032311 | Liver | HCC | respiratory tube development | 95/7958 | 181/18723 | 4.15e-03 | 1.81e-02 | 95 |
GO:00512241 | Liver | HCC | negative regulation of protein transport | 69/7958 | 127/18723 | 4.67e-03 | 2.01e-02 | 69 |
GO:190437611 | Liver | HCC | negative regulation of protein localization to cell periphery | 18/7958 | 26/18723 | 5.37e-03 | 2.24e-02 | 18 |
GO:001046621 | Liver | HCC | negative regulation of peptidase activity | 132/7958 | 262/18723 | 5.82e-03 | 2.42e-02 | 132 |
GO:003433211 | Liver | HCC | adherens junction organization | 30/7958 | 49/18723 | 6.31e-03 | 2.57e-02 | 30 |
GO:190547611 | Liver | HCC | negative regulation of protein localization to membrane | 21/7958 | 32/18723 | 7.02e-03 | 2.80e-02 | 21 |
GO:004825921 | Liver | HCC | regulation of receptor-mediated endocytosis | 60/7958 | 110/18723 | 7.12e-03 | 2.84e-02 | 60 |
GO:003559212 | Liver | HCC | establishment of protein localization to extracellular region | 176/7958 | 360/18723 | 7.96e-03 | 3.15e-02 | 176 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0512018 | Esophagus | ESCC | Epithelial cell signaling in Helicobacter pylori infection | 52/4205 | 70/8465 | 2.17e-05 | 1.07e-04 | 5.47e-05 | 52 |
hsa0512019 | Esophagus | ESCC | Epithelial cell signaling in Helicobacter pylori infection | 52/4205 | 70/8465 | 2.17e-05 | 1.07e-04 | 5.47e-05 | 52 |
hsa051202 | Liver | HCC | Epithelial cell signaling in Helicobacter pylori infection | 50/4020 | 70/8465 | 3.96e-05 | 2.16e-04 | 1.20e-04 | 50 |
hsa051203 | Liver | HCC | Epithelial cell signaling in Helicobacter pylori infection | 50/4020 | 70/8465 | 3.96e-05 | 2.16e-04 | 1.20e-04 | 50 |
hsa0512010 | Oral cavity | OSCC | Epithelial cell signaling in Helicobacter pylori infection | 49/3704 | 70/8465 | 7.57e-06 | 3.59e-05 | 1.83e-05 | 49 |
hsa0512017 | Oral cavity | OSCC | Epithelial cell signaling in Helicobacter pylori infection | 49/3704 | 70/8465 | 7.57e-06 | 3.59e-05 | 1.83e-05 | 49 |
hsa0512024 | Oral cavity | LP | Epithelial cell signaling in Helicobacter pylori infection | 38/2418 | 70/8465 | 5.17e-06 | 4.20e-05 | 2.71e-05 | 38 |
hsa0512034 | Oral cavity | LP | Epithelial cell signaling in Helicobacter pylori infection | 38/2418 | 70/8465 | 5.17e-06 | 4.20e-05 | 2.71e-05 | 38 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
CSK | SNV | Missense_Mutation | novel | c.115N>C | p.Val39Leu | p.V39L | P41240 | protein_coding | tolerated(0.52) | benign(0) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
CSK | SNV | Missense_Mutation | rs780001574 | c.296N>T | p.Pro99Leu | p.P99L | P41240 | protein_coding | tolerated(0.07) | benign(0.26) | TCGA-VS-A9UP-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | PD |
CSK | SNV | Missense_Mutation | rs749945630 | c.760N>A | p.Val254Met | p.V254M | P41240 | protein_coding | deleterious(0.01) | probably_damaging(0.94) | TCGA-AA-3984-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CSK | SNV | Missense_Mutation | rs200009296 | c.167N>A | p.Arg56His | p.R56H | P41240 | protein_coding | tolerated(0.07) | benign(0.011) | TCGA-AD-A5EJ-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CSK | SNV | Missense_Mutation | c.946G>A | p.Ala316Thr | p.A316T | P41240 | protein_coding | deleterious(0) | possibly_damaging(0.9) | TCGA-CK-4951-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
CSK | SNV | Missense_Mutation | c.956A>G | p.Asn319Ser | p.N319S | P41240 | protein_coding | deleterious(0) | probably_damaging(0.934) | TCGA-F4-6570-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
CSK | SNV | Missense_Mutation | rs754136671 | c.682N>A | p.Ala228Thr | p.A228T | P41240 | protein_coding | tolerated(0.56) | possibly_damaging(0.527) | TCGA-G4-6588-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
CSK | SNV | Missense_Mutation | c.952C>T | p.Arg318Cys | p.R318C | P41240 | protein_coding | deleterious(0) | probably_damaging(0.999) | TCGA-AG-A01W-01 | Colorectum | rectum adenocarcinoma | Female | >=65 | I/II | Chemotherapy | 5-fluorouracil | CR | |
CSK | SNV | Missense_Mutation | novel | c.454N>A | p.Leu152Met | p.L152M | P41240 | protein_coding | tolerated(0.51) | probably_damaging(0.969) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
CSK | SNV | Missense_Mutation | novel | c.103N>A | p.Val35Met | p.V35M | P41240 | protein_coding | tolerated(0.19) | benign(0.138) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | inhibitor | 223365983 | RIVOCERANIB | |
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | 936563-93-8 | |||
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | hydrochlorothiazide | HYDROCHLOROTHIAZIDE | 31327267 | |
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | inhibitor | 252827493 | ||
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | inhibitor | 249565754 | ||
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | BBI503 | |||
1445 | CSK | KINASE, DRUGGABLE GENOME, ENZYME, TYROSINE KINASE | inhibitor | HESPERADIN | HESPERADIN | 19035792 |
Page: 1 |